首页> 外国专利> METHOD FOR DESIGNING RECOMBINANT PLASMID DNA PGC S1-39 OF C-TERMINAL AMINOACIDS OF HEPATITIS B VIRUS WITH THE EPITOP P S1 (20-68) EXPOSED ON ITS SURFACE AND BACTERIAL STRAIN OF E COLI AS COR ANTIGEN PRODUCER DEPRIVED OF 39 C-TERMINAL AMINOACIDS OF HEPATITIS B VIRUS WITH THE EPITOP P S1 (20-68) EXPOSED ON ITS SURFACE

METHOD FOR DESIGNING RECOMBINANT PLASMID DNA PGC S1-39 OF C-TERMINAL AMINOACIDS OF HEPATITIS B VIRUS WITH THE EPITOP P S1 (20-68) EXPOSED ON ITS SURFACE AND BACTERIAL STRAIN OF E COLI AS COR ANTIGEN PRODUCER DEPRIVED OF 39 C-TERMINAL AMINOACIDS OF HEPATITIS B VIRUS WITH THE EPITOP P S1 (20-68) EXPOSED ON ITS SURFACE

机译:设计表位和细菌菌株暴露于大肠杆菌的表位P S1(20-68)的乙型肝炎病毒C末端氨基酸重组质粒PGC S1-39作为39种C末端氨基酸的抗原产物表面上暴露有EPITOP P S1(20-68)的乙型肝炎病毒

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to the microbiological and medical industry, genetic and protein engineering, and biotechnology.purpose to obtain u0438u0437u043eu0431u0440u0435u0442u0435u043du0438u00a0 u00a0u0432u043bu00a0u0435u0442u0441u00a0 cor - antigen virus hepatitis in man, with u0441u0440u043eu0434u0441u0442u0432u043eu043c to u043du0443u043au043bu0435u0438u043du043eu0432u044bu043c acids, and, in the case a u0445u0438u043cu0435u0440u043du044bu0445 protein structures on the surface of the u044du043au0441u043fu043eu043du0438u0440u0443u044eu0449u0438u0445 cor - antigen from 39 c end amino acid fragment of the preSIHBV x 20 to 68 amino acids.constructed a recombinant gene HBCAg a preSI (20 to 68), encrypting the synthesis of protein, u043fu043bu0430u0437u043cu0438u0434u0430 pGCSI - 140 u0434u043bu00a0 its expression, as well as the strain of e. coli is a producer / pGSI - 140 / re com - u0431u0438u043du0430u043du0442u043du043eu0439 u043au0430u043fu0441u0438u0434u043du043eu0439 structure u043du0432u0441u0430u0434 dr. u043du0432VpreS 1 (20 - 68) for the exit of product of not less than 26.7% of the total protein. 3 u0441.u043f.u0444 - lu 3, table 2).
机译:本发明用于微生物和医学,基因和蛋白质工程以及生物技术。目的是获得 u043e u0442 u043d u043e u0441 u0014的目的是为了获得 u0438 u0437 u043e u043e u0431 u0440 u0435 u0442 u0435 u043d u0438 u00a0 u00a0 u0432 u043b u00a0 u0435 u0442 u0441 u00a0 cor-患有人的抗原病毒性肝炎, u0441 u0440 u04340 u043e u0434 u0441 u0442 u0432 u043e u043c到 u043d u0443 u043a u043b u0435 u0438 u043d u043e u0432 u044b u043c酸,如果是 u0445 u0438 u043c u043c u0435 u04340 u04340 u043d u044b u04b u044d u043a u0441 u043f u043e u043d u0438 u0440 u0443 u044e u0449 u0438 u0445 cor表面的蛋白质结构-来自preSIHBV的39 c末端氨基酸片段的抗原x 20至68氨基酸构建了重组基因HBCAg a preSI(20至68),加密了蛋白质的合成 u043f u043b u0430 u0437 u043c u0438 u0434 u0430 pGCSI-140 u0434 u043b u00a0其表达,以及e的应变大肠杆菌是生产者 / pGSI-140 / com- u0431 u0438 u043d u0430 u043d u0442 u043d u043e u0439 u043a u0430 u043f u0441 u0438 u0434 u0434 u043d u043e u0439结构 u043d u0432 u0441 u0430 u0434 dr。 u043d u0432VpreS 1(20-68),表示产品出处的蛋白质不少于总蛋白的26.7%。 3 u0441。 u043f。 u0444-表3,表3)。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号